cvm_delam.htm

0001654954-26-003924.txt : 20260424 0001654954-26-003924.hdr.sgml : 20260424 20260424161109 ACCESSION NUMBER: 0001654954-26-003924 CONFORMED SUBMISSION TYPE: DEL AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260424 DATE AS OF CHANGE: 20260424 EFFECTIVENESS DATE: 20260424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: DEL AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-295168 FILM NUMBER: 26893908 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 DEL AM 1 cvm_delam.htm DEL AM cvm_delam.htm

CEL-SCI CORPORATION

8229 Boone Blvd. #802

Vienna, Virginia 22182

(703) 506-9460

April 23, 2026

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Re:

CEL-SCI Corporation

Registration Statement on Form S-1

SEC File No. 333-295168

The following is to be added to the cover page of the Company’s Registration Statement on Form S-1 filed on April 17, 2026.

Delaying Amendment

The Registrant hereby amends the Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment that specifically states that the Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act, or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to Section 8(a), may determine.

If you should have any questions concerning the foregoing, please do not hesitate to contact the undersigned.

	Very Truly Yours, CEL-SCI CORPORATION

	/s/ Geert Kersten
	Geert Kersten Chief Executive Officer